Schröder R, Johnson M A, Klinger H. "A Process for Preparing High-Purity 52943-14-3
3-Pyridinecarbonitrile, 2-(4-methyl-1-piperazinyl)-
5-23-03-00127 (Beilstein Handbook Reference)
BRN 0615192
(Methyl-4 piperazinyl)-2 nicotinonitrile [French]
2-(4-Methyl-1-piperazinyl)-3-pyridinecarbonitrile
Nicotinonitrile, 2-(4-methyl-1-piperazinyl)-
(Methyl-4 piperazinyl)-2 nicotinonitrile" [P]. US Patent, US 11184030 B2, 2016-07-18.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2024, 2458, 9583-9600.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Methods, 2019, 2221, (3), 2653-2673.
Kim S H, Park J Y. "Identification and Structural Characterization of a Novel Degradation Product of 52943-14-3
3-Pyridinecarbonitrile, 2-(4-methyl-1-piperazinyl)-
5-23-03-00127 (Beilstein Handbook Reference)
BRN 0615192
(Methyl-4 piperazinyl)-2 nicotinonitrile [French]
2-(4-Methyl-1-piperazinyl)-3-pyridinecarbonitrile
Nicotinonitrile, 2-(4-methyl-1-piperazinyl)-
(Methyl-4 piperazinyl)-2 nicotinonitrile Using HRMS and NMR". Sci. Total Environ., 2017, 2409, 3051-3054.
Yang F, Sun W, Liu J. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Chromatogr. A, 2014, 1163, (5), 8888-8893.